VR Solace for Pain and Anxiety Using Survey and Biodata
CompletedNot applicableNCT05468086
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to assess the therapeutic response to VR Solace in patients with chronic pain and anxiety using real-time clinical and survey data. Regression analysis of demographic characteristics, lab and survey data will be conducted to better understand the efficacy of VR Solace in treating chronic pain and anxiety. The investigator also aims to explore the possible association between the patient-reported changes in pain or anxiety levels with real-time physiological changes observed during VR Solace use.
Study details
- Official title
- Effects of Virtual Reality on Pain and Anxiety Using Validated Surveys and Biodata Analysis
- Conditions
- Interventions
- Device: VR Solace
- Sponsor
- Omer Liran
- Organization
- Cedars-Sinai Medical Center
- Start date
- 2022-08-30
- Primary completion
- 2023-06-28
- Sex
- All
- Age range
- from 18 Years to 99 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18+ * Endorsing pain/anxiety with objective measurement of 3 or greater on 10-point scale on validated survey * Diagnosis with chronic pain/anxiety Exclusion Criteria: * Exclusion of patients that are followed by CL Psychiatry team at Cedars-Sinai Medical Center to avoid overlap with another ongoing VR study * No active diagnosis of medical conditions that may cause physiological variations in vital signs (i.e. sepsis, cardiogenic shock/arrhythmia) * No active diagnosis of seizures, migraines, severe nausea, severe propensity for motion sickness, or facial/head deformities that would allow for comfortable placement of headset * Exclusions of patient currently taking beta blockers * Unable to communicate/read English for survey items * Unable to use VR independently - patients will be expected to maneuver through questions/steps of the VR system during the session
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05468086